vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× VALMONT INDUSTRIES INC). VALMONT INDUSTRIES INC runs the higher net margin — 10.5% vs 1.4%, a 9.1% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 6.2%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -0.5%).
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
SEM vs VMI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.0B |
| Net Profit | $20.2M | $108.0M |
| Gross Margin | — | 30.8% |
| Operating Margin | 4.6% | 15.1% |
| Net Margin | 1.4% | 10.5% |
| Revenue YoY | 6.4% | 6.2% |
| Net Profit YoY | 225.7% | 23.8% |
| EPS (diluted) | $0.17 | $5.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.4B | $1.0B | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.4B | $969.3M | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.3B | $1.0B |
| Q1 26 | — | $108.0M | ||
| Q4 25 | $20.2M | $168.0M | ||
| Q3 25 | $28.8M | $99.0M | ||
| Q2 25 | $40.6M | $-4.0M | ||
| Q1 25 | $56.7M | $87.3M | ||
| Q4 24 | $-16.1M | $77.7M | ||
| Q3 24 | $55.6M | $83.1M | ||
| Q2 24 | $77.6M | $99.7M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | 29.8% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | — | 30.6% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 30.8% |
| Q1 26 | — | 15.1% | ||
| Q4 25 | 4.6% | 11.2% | ||
| Q3 25 | 5.4% | 13.5% | ||
| Q2 25 | 6.5% | 2.8% | ||
| Q1 25 | 8.3% | 13.2% | ||
| Q4 24 | 1.6% | 11.6% | ||
| Q3 24 | 4.3% | 12.3% | ||
| Q2 24 | 5.8% | 14.2% |
| Q1 26 | — | 10.5% | ||
| Q4 25 | 1.4% | 16.2% | ||
| Q3 25 | 2.1% | 9.5% | ||
| Q2 25 | 3.0% | -0.4% | ||
| Q1 25 | 4.2% | 9.0% | ||
| Q4 24 | -1.2% | 7.5% | ||
| Q3 24 | 4.4% | 8.1% | ||
| Q2 24 | 6.1% | 9.6% |
| Q1 26 | — | $5.51 | ||
| Q4 25 | $0.17 | $9.02 | ||
| Q3 25 | $0.23 | $4.98 | ||
| Q2 25 | $0.32 | $-1.53 | ||
| Q1 25 | $0.44 | $4.32 | ||
| Q4 24 | $-0.12 | $3.85 | ||
| Q3 24 | $0.43 | $4.11 | ||
| Q2 24 | $0.60 | $4.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.5M | $160.2M |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $1.7B | $1.7B |
| Total Assets | $5.9B | $3.4B |
| Debt / EquityLower = less leverage | 1.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $160.2M | ||
| Q4 25 | $26.5M | $187.1M | ||
| Q3 25 | $60.1M | $226.1M | ||
| Q2 25 | $52.3M | $208.5M | ||
| Q1 25 | $53.2M | $184.4M | ||
| Q4 24 | $59.7M | $164.3M | ||
| Q3 24 | $191.5M | $200.5M | ||
| Q2 24 | $111.2M | $163.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $795.7M | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | $730.6M | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.6B | — |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.7B | $1.6B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.9B | $1.5B | ||
| Q2 24 | $1.4B | $1.5B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $5.9B | $3.4B | ||
| Q3 25 | $5.7B | $3.4B | ||
| Q2 25 | $5.7B | $3.3B | ||
| Q1 25 | $5.7B | $3.4B | ||
| Q4 24 | $5.6B | $3.3B | ||
| Q3 24 | $8.0B | $3.5B | ||
| Q2 24 | $7.9B | $3.5B |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | 0.49× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 1.01× | 0.47× | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 2.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.3M | — |
| Free Cash FlowOCF − Capex | $5.2M | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | 3.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $64.3M | $111.2M | ||
| Q3 25 | $175.3M | $112.5M | ||
| Q2 25 | $110.3M | $167.6M | ||
| Q1 25 | $-3.5M | $65.1M | ||
| Q4 24 | $125.4M | $193.4M | ||
| Q3 24 | $181.0M | $225.1M | ||
| Q2 24 | $278.2M | $130.8M |
| Q1 26 | — | — | ||
| Q4 25 | $5.2M | $70.4M | ||
| Q3 25 | $122.2M | $70.6M | ||
| Q2 25 | $45.6M | $135.6M | ||
| Q1 25 | $-55.8M | $34.8M | ||
| Q4 24 | $62.0M | $167.8M | ||
| Q3 24 | $130.3M | $204.6M | ||
| Q2 24 | $222.6M | $112.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 6.8% | ||
| Q3 25 | 9.0% | 6.7% | ||
| Q2 25 | 3.4% | 12.9% | ||
| Q1 25 | -4.1% | 3.6% | ||
| Q4 24 | 4.7% | 16.2% | ||
| Q3 24 | 10.2% | 20.1% | ||
| Q2 24 | 17.4% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 3.9% | ||
| Q3 25 | 3.9% | 4.0% | ||
| Q2 25 | 4.8% | 3.0% | ||
| Q1 25 | 3.9% | 3.1% | ||
| Q4 24 | 4.8% | 2.5% | ||
| Q3 24 | 4.0% | 2.0% | ||
| Q2 24 | 4.3% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.19× | 0.66× | ||
| Q3 25 | 6.09× | 1.14× | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | -0.06× | 0.75× | ||
| Q4 24 | — | 2.49× | ||
| Q3 24 | 3.25× | 2.71× | ||
| Q2 24 | 3.59× | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
VMI
| Infrastructure | $803.2M | 78% |
| Agriculture | $226.0M | 22% |
